risperidone has been researched along with clopenthixol decanoate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| Pischinger, B; Rosenleitner, J; Yazdi, K | 1 |
1 trial(s) available for risperidone and clopenthixol decanoate
| Article | Year |
|---|---|
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
1 other study(ies) available for risperidone and clopenthixol decanoate
| Article | Year |
|---|---|
[Combination of two depot antipsychotic drugs].
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Risperidone; Schizophrenia; Treatment Outcome | 2014 |